$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

$eltp Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223004896 Filed on February 14, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2021 Q4
Revenue	$8.642M	$9.250M	$8.975M
YoY Change	12.64%	3.07%	48.43%
Cost Of Revenue	$5.200M	$4.331M	$4.957M
YoY Change	22.15%	-12.63%	87.54%
Gross Profit	$3.441M	$4.919M	$4.018M
YoY Change	0.78%	22.44%	18.05%
Gross Profit Margin	39.82%	53.18%	44.77%
Selling, General & Admin	$799.5K	$1.199M	$933.2K
YoY Change	-48.0%	28.49%	12.75%
% of Gross Profit	23.23%	24.38%	23.23%
Research & Development	$2.425M	$1.443M	$956.6K
YoY Change	228.24%	50.88%
% of Gross Profit	70.47%	29.34%	23.81%
Depreciation & Amortization	$344.1K	$314.6K	$296.6K
YoY Change	14.38%	6.09%	-9.83%
% of Gross Profit	10.0%	6.4%	7.38%
Operating Expenses	$3.535M	$2.960M	$2.186M
YoY Change	37.94%	35.39%	-8.99%
Operating Profit	-$94.09K	$1.959M	$1.831M
YoY Change	-111.05%	6.98%	82.92%
Interest Expense	-$469.2K	$322.7K	$452.1K
YoY Change	187.16%	-28.63%	-54.97%
% of Operating Profit		16.47%	24.69%
Other Income/Expense, Net		$1.050M	$452.1K
YoY Change		132.29%
Pretax Income	-$856.1K	$3.009M	$2.283M
YoY Change	-224.37%	31.79%	13.48%
Income Tax	$373.2K	$39.25K
% Of Pretax Income		1.3%
Net Earnings	-$1.229M	$2.970M	$2.283M
YoY Change	-150.61%	30.07%	13.48%
Net Earnings / Revenue	-14.22%	32.11%	25.44%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$2.258K
COMMON SHARES
Basic Shares Outstanding	1.014B shares	1.014B shares	1.011B shares
Diluted Shares Outstanding		1.014B shares	1.011B shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.832M	$17.91M	$7.288M
YoY Change	-8.24%	145.72%	34.65%
Cash & Equivalents	$7.832M	$17.91M	$7.693M
Short-Term Investments
Other Short-Term Assets	$1.033M	$1.108M	$831.1K
YoY Change	95.99%	33.33%	-19.09%
Inventory	$9.551M	$8.602M	$6.694M
Prepaid Expenses
Receivables	$3.095M	$5.546M	$2.661M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$21.51M	$33.16M	$17.48M
YoY Change	14.04%	89.78%	20.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.43M	$10.23M	$7.068M
YoY Change	75.14%	44.73%	1.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$21.02K	$91.74K	$364.6K
YoY Change	-77.09%	-74.84%	297.38%
Other Assets	$2.584M	$2.577M	$405.0K
YoY Change	0.29%	536.25%	0.0%
Total Long-Term Assets	$19.39M	$19.55M	$14.47M
YoY Change	19.02%	35.1%	2.44%
TOTAL ASSETS
Total Short-Term Assets	$21.51M	$33.16M	$17.48M
Total Long-Term Assets	$19.39M	$19.55M	$14.47M
Total Assets	$40.90M	$52.72M	$31.95M
YoY Change	16.35%	65.01%	11.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.447M	$1.472M	$1.284M
YoY Change	70.99%	14.63%	83.24%
Accrued Expenses	$5.048M	$4.676M	$4.180M
YoY Change	7.56%	11.87%	-13.39%
Deferred Revenue	$13.33K	$13.33K
YoY Change	0.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$310.9K	$471.4K	$400.4K
YoY Change	-12.15%	17.74%	-76.47%
Total Short-Term Liabilities	$7.834M	$6.654M	$5.878M
YoY Change	17.02%	13.2%	-18.84%
LONG-TERM LIABILITIES
Long-Term Debt	$3.562M	$15.49M	$1.433M
YoY Change	156.43%	980.9%	-47.8%
Other Long-Term Liabilities			$1.846M
YoY Change			-9.81%
Total Long-Term Liabilities	$4.102M	$15.89M	$3.279M
YoY Change	26.9%	384.49%	-31.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.834M	$6.654M	$5.878M
Total Long-Term Liabilities	$4.102M	$15.89M	$3.279M
Total Liabilities	$11.94M	$22.54M	$9.157M
YoY Change	20.24%	146.16%	-23.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$136.5M	-$135.3M
YoY Change	-2.54%
Common Stock	$1.014M	$1.014M
YoY Change	0.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$306.8K	$306.8K
YoY Change	0.0%
Treasury Stock Shares		100.0K shares
Shareholders Equity	$28.96M	$30.17M	$22.79M
YoY Change
Total Liabilities & Shareholders Equity	$40.90M	$52.72M	$31.95M
YoY Change	16.35%	65.01%	11.45%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	-$1.229M	$2.970M	$2.283M
YoY Change	-150.61%	30.07%	13.48%
Depreciation, Depletion And Amortization	$344.1K	$314.6K	$296.6K
YoY Change	14.38%	6.09%	-9.83%
Cash From Operating Activities	$2.969M	-$567.9K	$3.034M
YoY Change	84.93%	-118.72%	145.59%
INVESTING ACTIVITIES
Capital Expenditures	$536.2K	$710.00	-$82.08K
YoY Change	-302.97%	-100.87%	63.41%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$536.2K	-$710.00	-$82.08K
YoY Change	102.97%	-99.13%	117.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-12.50M	-77.37K	-153.9K
YoY Change	13166.16%	-49.71%	2.27%
NET CHANGE
Cash From Operating Activities	2.969M	-567.9K	3.034M
Cash From Investing Activities	-536.2K	-710.0	-82.08K
Cash From Financing Activities	-12.50M	-77.37K	-153.9K
Net Change In Cash	-10.07M	-646.0K	2.798M
YoY Change	-907.56%	-123.09%	167.19%
FREE CASH FLOW
Cash From Operating Activities	$2.969M	-$567.9K	$3.034M
Capital Expenditures	$536.2K	$710.00	-$82.08K
Free Cash Flow	$2.432M	-$568.6K	$3.116M
YoY Change	30.11%	-118.25%	142.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07647
	dei	City Area Code CityAreaCode	201
	dei	Entity Central Index Key EntityCentralIndexKey	0001053369
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss		usd
CY2021Q4	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss		usd
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1		usd
	ELTP	Supplemental Noncash Amounts Of Lease Liabilities Arising From Obtaining Right Of Use Assets SupplementalNoncashAmountsOfLeaseLiabilitiesArisingFromObtainingRightOfUseAssets		usd
CY2022Q4	us-gaap	Dilutive Securities DilutiveSecurities		usd
CY2021Q4	us-gaap	Dilutive Securities DilutiveSecurities		usd
	us-gaap	Dilutive Securities DilutiveSecurities		usd
	us-gaap	Dilutive Securities DilutiveSecurities		usd
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1		usd
	ELTP	Finitelived Intangible Assets Reductions FinitelivedIntangibleAssetsReductions		usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1		usd
CY2022	ELTP	Finitelived Intangible Assets Reductions FinitelivedIntangibleAssetsReductions		usd
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent		usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo		usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree		usd
CY2022Q4	ELTP	Lessee Operating Lease Liability Payments Due After Year Three LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree		usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-15697
	dei	Entity Registrant Name EntityRegistrantName	ELITE PHARMACEUTICALS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-3542636
	dei	Local Phone Number LocalPhoneNumber	750-2646
	dei	Entity Address Address Line1 EntityAddressAddressLine1	165 LUDLOW AVENUE
	dei	Entity Address City Or Town EntityAddressCityOrTown	NORTHVALE
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	ELTP
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1013915081	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17909077	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8535357	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5545843	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3057913	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8601858	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	6741170	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1108062	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	526949	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	33164840	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	18861389	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14271930	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13348565	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10230034	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5952992	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6634035	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6634035	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18502	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1031884	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2171821	usd
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2171821	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	405164	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	405039	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	91738	usd
CY2022Q1	us-gaap	Security Deposit SecurityDeposit	91738	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	496902	usd
CY2022Q1	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	496777	usd
CY2022Q4	us-gaap	Assets Assets	52716134	usd
CY2022Q1	us-gaap	Assets Assets	35148898	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1472198	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1430985	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4676244	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4693142	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	13333	usd
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	13333	usd
CY2022Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	110822	usd
CY2022Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	100822	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	360616	usd
CY2022Q1	us-gaap	Loans Payable Current LoansPayableCurrent	253006	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	21149	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	202953	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6654362	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6694241	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	22223	usd
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	32226	usd
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	1025479	usd
CY2022Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	1139848	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	14463789	usd
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	249046	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	835893	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	375767	usd
CY2022Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	936837	usd
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	38780	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15887258	usd
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3232630	usd
CY2022Q4	us-gaap	Liabilities Liabilities	22541620	usd
CY2022Q1	us-gaap	Liabilities Liabilities	9926871	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1445000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1445000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1014015081	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1011381988	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1013915081	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1011281988	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1014019	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	1011385	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	164735980	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	164577227	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	100000	shares
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	100000	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	306841	usd
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	306841	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135268644	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-140059744	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	30174514	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	25222027	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52716134	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35148898	usd
CY2022Q4	ELTP	Revenue From Manufacturing Fees RevenueFromManufacturingFees	7798159	usd
CY2021Q4	ELTP	Revenue From Manufacturing Fees RevenueFromManufacturingFees	7667674	usd
	ELTP	Revenue From Manufacturing Fees RevenueFromManufacturingFees	21312663	usd
	ELTP	Revenue From Manufacturing Fees RevenueFromManufacturingFees	20639421	usd
CY2022Q4	ELTP	Revenue From Licensing Fees RevenueFromLicensingFees	1451907	usd
CY2021Q4	ELTP	Revenue From Licensing Fees RevenueFromLicensingFees	1307140	usd
	ELTP	Revenue From Licensing Fees RevenueFromLicensingFees	4200888	usd
	ELTP	Revenue From Licensing Fees RevenueFromLicensingFees	3950623	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9250066	usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8974814	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25513551	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24590044	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	4330841	usd
CY2021Q4	us-gaap	Cost Of Revenue CostOfRevenue	4957150	usd
	us-gaap	Cost Of Revenue CostOfRevenue	12360935	usd
	us-gaap	Cost Of Revenue CostOfRevenue	13209430	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	4919225	usd
CY2021Q4	us-gaap	Gross Profit GrossProfit	4017664	usd
	us-gaap	Gross Profit GrossProfit	13152616	usd
	us-gaap	Gross Profit GrossProfit	11380614	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1443361	usd
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	956628	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3775107	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3312540	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1186049	usd
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	929547	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4356752	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2930126	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13030	usd
CY2021Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3630	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24325	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10617	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	317685	usd
CY2021Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	296559	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	933531	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	908297	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	2960125	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	2186364	usd
	us-gaap	Operating Expenses OperatingExpenses	9089715	usd
	us-gaap	Operating Expenses OperatingExpenses	7161580	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	1959100	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	1831300	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	4062901	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	4219034	usd
CY2022Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	372894	usd
CY2021Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	489500	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	561070	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1523394	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	322681	usd
CY2021Q4	us-gaap	Interest Expense InterestExpense	37400	usd
	us-gaap	Interest Expense InterestExpense	782221	usd
	us-gaap	Interest Expense InterestExpense	126376	usd
CY2022Q4	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000000	usd
CY2022Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	15	usd
CY2021Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	13	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	187	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	77	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1050228	usd
CY2021Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	452113	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	779036	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1397095	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3009328	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2283413	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4841937	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5616129	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39250	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	50837	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	usd
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	857379	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	2970078	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	2283413	usd
	us-gaap	Net Income Loss NetIncomeLoss	4791100	usd
	us-gaap	Net Income Loss NetIncomeLoss	6469508	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1013915081	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1011281988	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1012480115	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1010416823	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1013915081	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1011281988	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1012480115	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1010416823	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	25222027	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	305883	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5322	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	25533232	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1515139	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5974	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	60000	usd
CY2022Q3	ELTP	Shares Issued In Payment Of Consulting Expenses SharesIssuedInPaymentOfConsultingExpenses	77062	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	27191407	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	2970078	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	30174514	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13029	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	16151929	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	462889	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14204231	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-572889	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	2389118	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2811	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	157500	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	18701358	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	1796977	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4176	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	20502511	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	2283413	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3630	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	22789554	usd
	us-gaap	Net Income Loss NetIncomeLoss	4791100	usd
	us-gaap	Net Income Loss NetIncomeLoss	6469508	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	933531	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	908297	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	61621	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	175306	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	561070	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1523394	usd
	ELTP	Accrued Compensation Non Cash AccruedCompensationNonCash	430778	usd
	ELTP	Accrued Compensation Non Cash AccruedCompensationNonCash	641664	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	24325	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	10617	usd
	ELTP	Noncash Rent Expense And Lease Accretion NoncashRentExpenseAndLeaseAccretion	602	usd
	ELTP	Noncash Rent Expense And Lease Accretion NoncashRentExpenseAndLeaseAccretion	559	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2487930	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-834963	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1860688	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1681168	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	581113	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	367154	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-309950	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-373820	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-10003	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-9999	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-61182	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-182401	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	370021	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4902978	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	5200407	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	234387	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5200407	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-234387	usd
	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	115000	usd
	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	110000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	14550001	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	230770	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	9373845	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	4095702	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8940396	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3597781	usd
	us-gaap	Interest Paid Net InterestPaidNet	782221	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18314241	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7693483	usd
	us-gaap	Interest Paid Net InterestPaidNet	126376	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	127522	usd
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	244124	usd
	us-gaap	Stock Issued1 StockIssued1	137063	usd
	us-gaap	Stock Issued1 StockIssued1	157500	usd
	ELTP	Supplemental Noncash Amounts Of Lease Liabilities Arising From Obtaining Right Of Use Assets SupplementalNoncashAmountsOfLeaseLiabilitiesArisingFromObtainingRightOfUseAssets	1042800	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9250066	usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8974814	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25513551	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24590044	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3342972	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4791100	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6469508	usd
CY2022Q4	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	372894	usd
CY2021Q4	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-489500	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	561070	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	405164	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	405039	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-1523394	usd
	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	These tax benefits are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000000	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2970078	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2283413	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1793913	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5352170	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4946114	usd
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1013915081	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1011281988	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1012480115	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1010416823	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1013915081	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1011281988	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1012480115	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1010416823	shares
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	936837	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	561070	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	375767	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6634035	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10230034	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	327827	usd
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	159808	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	99283	usd
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1203204	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	8174748	usd
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5378158	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8601858	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	6741170	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24501964	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19301557	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14271930	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13348565	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5952992	usd
CY2022Q4	us-gaap	Depreciation Depreciation	314610	usd
CY2021Q4	us-gaap	Depreciation Depreciation	293014	usd
	us-gaap	Depreciation Depreciation	923365	usd
	us-gaap	Depreciation Depreciation	897662	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6634035	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6634035	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6634035	usd
CY2020Q4	ELTP	Operating Lease Renewal Term OperatingLeaseRenewalTerm	The Pompano Office Lease is for approximately 1,275 square feet of office space, with Elite taking occupancy on November 1, 2020. The Pompano Office has a term of three years, ending on October 31, 2023.
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	6330	usd
CY2021Q4	us-gaap	Payments For Rent PaymentsForRent	63249	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4000000	usd
CY2022Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3625000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	54550	usd
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	414989	usd
CY2022Q4	ELTP	Accrued Consultant Contract Fees AccruedConsultantContractFees	153333	usd
CY2022Q1	ELTP	Accrued Consultant Contract Fees AccruedConsultantContractFees	153333	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	144000	usd
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	140000	usd
CY2022Q4	ELTP	Accrued Director Dues AccruedDirectorDues	67500	usd
CY2022Q1	ELTP	Accrued Director Dues AccruedDirectorDues	90000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	104386	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	37500	usd
CY2022Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	143000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	114975	usd
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	126820	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4676244	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4693142	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6744	usd
CY2022Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	7367	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	35556	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13333	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	22223	usd
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	45559	usd
CY2022Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13333	usd
CY2022Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	32226	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	14824405	usd
CY2022Q1	us-gaap	Loans Payable LoansPayable	502052	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	360616	usd
CY2022Q1	us-gaap	Loans Payable Current LoansPayableCurrent	253006	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	14463789	usd
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	249046	usd
CY2022Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	317844	usd
CY2021Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	14692	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	579109	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	50290	usd
	us-gaap	Payments For Rent PaymentsForRent	77238	usd
	us-gaap	Payments For Rent PaymentsForRent	189003	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	6330	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	14840	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	21170	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	21	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	21149	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1521
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1521
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P4Y3M18D
CY2022Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y1M6D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5650000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.14
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4100000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.04
	ELTP	Sharebased Compensation Arrangement By Sharebased Payment Award Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingContractualTermGranted	P4Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9750000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.17
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y3M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4530001	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.16
	ELTP	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableOutstandingWeightedAverageRemainingContractualTerm	P1Y9M18D
CY2022Q4	ELTP	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Stock Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPrice	0.03
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.04
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.636	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.040	pure
CY2022Q4	ELTP	Price Difference Between Exercise Price And Quoted Price PriceDifferenceBetweenExercisePriceAndQuotedPrice	0.03
CY2022Q1	ELTP	Price Difference Between Exercise Price And Quoted Price PriceDifferenceBetweenExercisePriceAndQuotedPrice	0.03
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	95888	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.115	pure
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	50837	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.1075	pure
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	usd
	ELTP	Effective Income Tax Rate Reconciliation Valuation Allowance Tax Rate EffectiveIncomeTaxRateReconciliationValuationAllowanceTaxRate	0.21	pure

Files In Submission

Name	View Source	Status
0001493152-23-004896-index-headers.html	Edgar Link	pending
0001493152-23-004896-index.html	Edgar Link	pending
0001493152-23-004896.txt	Edgar Link	pending
0001493152-23-004896-xbrl.zip	Edgar Link	pending
eltp-20221231.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
eltp-20221231_cal.xml	Edgar Link	unprocessable
eltp-20221231_def.xml	Edgar Link	unprocessable
eltp-20221231_lab.xml	Edgar Link	unprocessable
eltp-20221231_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

2023 Q1 Form 10-Q Financial Statement

#000149315223004896 Filed on February 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELTP ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

2023 Q1 Form 10-Q Financial Statement

#000149315223004896 Filed on February 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp